Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer—a Danish Oncological Lung Cancer Group (DOLG) phase II trial
Keyword(s):
Phase Ii
◽
2013 ◽
Vol 73
(3)
◽
pp. 451-457
◽